학술논문
First-in-human Intravesical Delivery of Pembrolizumab Identifies Immune Activation in Bladder Cancer Unresponsive to Bacillus Calmette-Guérin
Document Type
Article
Author
Source
In: European Urology . (European Urology, December 2022, 82(6):602-610)
Subject
Language
English
ISSN
18737560
03022838
03022838